Current Opinion in Nephrology and Hypertension was launched in 1992. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of nephrology and hypertension is divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Agnes B Fogo
Agnes Borge Fogo completed her medical training at Vanderbilt University Medical School. She has remained at Vanderbilt for residency in pathology, and for further training in renal pathology with the late Dr. Alan Glick and in experimental renal diseases with Dr. Iekuni Ichikawa. Her main research interests are focused on progression of chronic kidney disease and the renin angiotensin aldosterone system and its link to the fibrinolytic/thrombolytic plasmin/plasminogen activator system. In recent years, she has explored the possibility of regression of sclerosis. She is also dedicated to diagnostic renal pathology, and has created an online Atlas of Renal Pathology with the American Journal of Kidney Disease and the National Kidney Foundation, and enjoys being involved with teaching renal pathology. She is currently professor of pathology, medicine and pediatrics and director of the Renal/Electron Microscopy Laboratory at Vanderbilt University Medical Center.
Gary C Curhan
Dr Curhan is a nephrologist and epidemiologist and divides his time between the Channing Laboratory and the Renal Division at the Brigham and Women's Hospital. He is an Associate Professor of Medicine and Epidemiology at Harvard Medical School and Harvard School of Public Health. His research interests include: the relation between chronic analgesic use and the risk of chronic renal failure; modifiable risk factors for renal function decline; risk factors for kidney stones in men and women; modifiable risk factors for gout; novel risk factors for hypertension; and the relation between rheumatoid arthritis and cardiovascular disease. Additional areas of active research include epidemiologic studies of pneumonia, incontinence, and painful bladder syndrome. He serves on a number of Advisory and Executive Committees for the NIDDK/NIH. In addition to his clinical practice, he teaches at Harvard Medical School and Harvard School of Public Health and mentors several renal fellows and junior faculty members.
Dr. Chi-yuan Hsu is a native of Hong Kong who graduated from Yale University with simultaneous B.S. and M.S. degrees in 1989. He obtained his M.D. from Harvard Medical School and completed his internal medicine residency at Boston's Beth Israel Hospital. Dr. Hsu went on to a nephrology fellowship at the Massachusetts General Hospital and graduated from the Harvard School of Public Health with a M.Sc. degree in epidemiology.
Since 1999, Dr. Hsu has been a faculty member in the Division of Nephrology at University of California San Francisco (UCSF). He divides his time between patient care and clinical research. His research has been supported by the National Institutes of Health and focuses on the epidemiology and consequences of chronic kidney disease. Dr. Hsu's papers have been published in the Annals of Internal Medicine, the Journal of the American Medical Association, the Journal of the American Society of Nephrology, Kidney International and the New England Journal of Medicine. He is active in the American Society of Nephrology as a member of the Clinical Science Committee and an associate editor of NephSAP.